Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100920004780N11Phase 3Completed
Phase 3, randomised, double-blind trial of dexmedetomidine in anal fissure and hemorrhoid (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pain intensity, Nausea and 3 more. Started Aug 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100920004780N11.